Rectal Cancer
📧 Sign up to get email alerts when something new happens for Rectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal Cancer
This ClinicalTrials.gov entry describes an ongoing study evaluating the clinical relevance of lymph node pathologic regression in locally ad…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Clinical Relevance of Major Pathologic Regression for Locally Advanced Rectal Cancer
A completed clinical trial update evaluates the clinical relevance of major pathologic regression in locally advanced rectal cancer. It disc…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Microsatellite Stable Locally Advanced Rectal Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating CapeOX plus bevacizumab and an anti-PD1 antibody for microsatellite-stable locally advanced rectal/colo…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial [Phase 3]
The Phase 3 VAPOR-C trial evaluating volatile anesthesia and perioperative outcomes in cancer patients has been terminated, including colon …
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma (PRECAM) [Phase 2]
Phase 2 PRECAM trial evaluating preoperative short-course radiation followed by Envafolimab plus CAPEOX in microsatellite-stable locally adv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer [Phase 2]
Phase 2 clinical trial of neoadjuvant chemoradiation with Nal-IRI and capecitabine guided by UGT1A1 status in rectal cancer; currently recru…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Clinical trial evaluating adaptive boost radiotherapy to primary rectal lesions and positive lymph nodes as part of neoadjuvant treatment fo…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Short-course Radiation (SCRT) Followed by 6 Cycles of Cadonilimab Plus MFOLFOX6 As Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer (LARC): a Multicenter, Two-arm Parallel, Open-label, Randomised Phase III Trial (NeoCaCRT-III) [Phase 3]
A multicenter, randomized Phase III trial evaluating short-course radiotherapy followed by Cadonilimab plus MFOLFOX6 as neoadjuvant therapy …
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Neoadjuvant Therapy for Locally Advanced Rectal Cancer [EARLY_Phase 1]
This document provides a clinical trial update for neoadjuvant therapy in locally advanced rectal cancer. The trial is at EARLY Phase 1, spo…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: the Effect of Environmental Factors on Colorectal Cancer Based on Macrogenomes
A clinical trial exploring how environmental factors influence colorectal cancer using macrogenome data; currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer [Phase 2]
Phase 2 trial update on an organ-preservation approach for rectal cancer using short-course radiation plus the FOLFOXIRI chemotherapy regime…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases [Phase 2]
Phase 2 study evaluating preoperative chemoradiotherapy with or without induction chemotherapy for rectal cancer with liver metastases has c…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: DataBase for Analysis of Rectal Cancer Oncological Results
Completed update of a clinical trial database analyzing rectal cancer oncological outcomes, with metformin as a condition of interest and en…
-
CLINICAL_TRIALS other · 2025-02-25Clinical Trial Update: Radiological Markers in Locally Advanced Rectal Cancer
Clinical trial entry for Radiological Markers in Locally Advanced Rectal Cancer; status not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Comprehensive Management of Rectal Cancer
This entry reports the completion of a clinical trial studying comprehensive management of rectal cancer.
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients [Phase 1]
Phase 1 trial evaluating capecitabine-based chemoradiotherapy with the IL-1 receptor antagonist anakinra for rectal cancer has completed. No…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer [Phase 2]
This Phase 2 trial evaluates MR-guided adaptive radiotherapy combined with a PD-1 antibody and CAPOX chemotherapy for locally advanced recta…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Neoadjuvant FOLFIRINOX and Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Patients [Phase 2]
Phase 2 trial evaluating neoadjuvant FOLFIRINOX combined with preoperative chemoradiotherapy for locally advanced rectal cancer is currently…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: RATME Vs LATME in Middle and Low Rectal Cancer [NA]
A clinical trial comparing RATME versus LATME surgical techniques for middle and low rectal cancer, currently not recruiting.
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: PRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsatellite Unstable or Mismatch Repair-deficient Locally Advanced Rectal Cancer Patients [Phase 3]
Phase 3 trial evaluating neoadjuvant dostarlimab with short-course radiotherapy in a watch-and-wait strategy for mismatch repair-deficient o…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Hyperthermia With Chemoradiotherapy in Rectal Cancer [NA]
A clinical trial is currently recruiting to evaluate the combination of hyperthermia with chemoradiotherapy in rectal cancer.
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
This clinical trial update covers results from a study evaluating the financial burden on patients with Stage I-III colon or rectal cancer u…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer [Phase 1]
A Phase 1 study of the live biotherapeutic GB104 in colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: The Longitudinal Study of Low Anterior Resection Syndrome in Patients with Newly Diagnosed Rectal Cancer.
This is a completed longitudinal clinical trial evaluating low anterior resection syndrome in patients with newly diagnosed rectal cancer. T…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Development of a Clinical and Biological Database in Rectum Cancer [NA]
Development of a clinical and biological database for rectal neoplasms is underway, with the study currently recruiting. The sponsor is Inst…